Reaction
Orthostatic Intolerance reporting signals
As of the last recalculation, Orthostatic Intolerance appears in 704 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is CAPTOPRIL (PRR 50.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Captopril | 16 | 50.3 | 50.4 |
| Nebivolol | 26 | 50.1 | 50.2 |
| Rotigotine | 22 | 46.4 | 46.5 |
| Torsemide | 44 | 41.8 | 41.9 |
| Febuxostat Tablets 40 Mg | 13 | 38.5 | 38.5 |
| Febuxostat Tablets 80 Mg | 13 | 38.5 | 38.5 |
| Guanfacine | 10 | 38.1 | 38.1 |
| Pramipexole | 19 | 37.6 | 37.7 |
| Felodipine Extended-Release Tablets | 13 | 34.4 | 34.4 |
| Felodipine | 13 | 34.4 | 34.4 |
| Levodopa | 12 | 29.9 | 29.9 |
| Rasagiline Mesylate | 11 | 29.7 | 29.7 |
| Nebivolol Hydrochloride | 27 | 24.6 | 24.6 |
| Febuxostat | 13 | 23.3 | 23.4 |
| Valsartan Oral | 39 | 22.4 | 22.4 |
| Granisetron Hydrochloride | 6 | 17.1 | 17.1 |
| Granisetron | 6 | 17.0 | 17.1 |
| Baricitinib | 5 | 15.4 | 15.4 |
| Droxidopa | 11 | 15.3 | 15.3 |
| Bendamustine Hydrochloride | 5 | 12.4 | 12.4 |
| Lapatinib | 5 | 9.6 | 9.6 |